MRC Laboratory of Molecular Biology
One of the world's leading research institutes, our scientists are working to advance understanding of biological processes at the molecular level - providing the knowledge needed to solve key problems in human health.
The next president of the Royal Society will be the Nobel-winning LMB researcher Venki Ramakrishnan. He will succeed Paul Nurse in December 2015. After hearing of the confirmation, Venki told the BBC News that he was “very honoured” to be the society’s president elect. More…
LMB scientists have found a reaction network that they believe shows that ‘pretty much everyone’ working on life’s molecular origins is wrong – but also ‘right, in a sense’. Until now, the field has warred over which biomolecule, emerged first. But John Sutherland’s group found the different types may have appeared simultaneously. More…
LMB’s Kiyoshi Nagai looks back on his research on the spliceosome, RNA-protein interactions and the RNA recognition motif, U1A protein, for RNA journal. More…
The Telegraph reports that the LMB spin-out company Heptares has been acquired by Japanese pharmaceutical company Soseito. The group’s research and development activities and 72 employees will remain in Hertfordshire, and Heptares will operate as an autonomous subsidiary to Sosei. Heptares is developing a string of drugs using a technology which can determine the precise shape of the target molecule, originally developed in the LMB. Its most advanced drug, which aims to treat Alzheimer’s, recently entered human trials. More…
Architectural photographer, David Porter, explores LMB for Cambridge Business magazine, pages 65-69. More…
The DNA Sequencing technique, developed by Fred Sanger at the MRC Laboratory of Molecular Biology, is highlighted as one of eight key inventions of the past century, on a new set of stamps, ‘Inventive Britain’ from the Royal Mail. This article is no longer available from the source website: Royal Mail News 19 February 2015